Menu

IGF-LR3/CJC-1295/Ipamorelin

0.0
0 orders In stock
344.00

IGF-LR3/CJC-1295/Ipamorelin

Type:
Medicine
Prescription Required:
Login to check prescription requirements.
Concentration:
40 mcg/250 mcg/150 mcg
Form:
Combination
Dosage:
Inject subcutaneously daily for 6 days and 1 day off.

Save

IGF-LR3/CJC-1295/Ipamorelin

Key Features
  • Dual Pulse Modulation - Amplitude + Frequency
  • Train-Recover-Repeat - Session Quality
  • 6-On / 1-Off - Responsiveness Preservation
  • Downstream Recovery - IGF-Backed Repair
  • Sleep Alignment - Bedtime Friendly
  • Subcutaneous-Route - At-Home Ease
Product Specifications
Concentration: 40 mcg/250 mcg/150 mcg
Form: Combination
Dosage: Inject subcutaneously daily for 6 days and 1 day off.
Manufactured Date: 05 Oct, 2025
Shelf Life: 100 Days
SKU: igf_52461a
Category: Energy and Physical Performance
Vendor: PTNL
Use Cases
  • IGF-1 Increase
  • Muscle
  • Energy
How to Use IGF-LR3/CJC-1295/Ipamorelin

How to Use — Step-by-Step (Subcutaneous)

Preparation

  • Wash Your Hands – Soap and water.

  • Prepare the Site – Abdomen, thigh, or upper arm; clean with an alcohol swab; let air-dry.

Prepare the Injection

  • Inspect Vial – Solution should be clear and particle-free.

  • Draw Dose – Using a sterile insulin syringe, draw the prescribed volume that corresponds to your clinician’s mcg target (see your pharmacy label).

  • Remove Air – Tap syringe gently; expel bubbles.

Administration

  • Pinch Skin – Create a small fold.

  • Insert Needle – ~45° into subcutaneous tissue.

  • Inject Slowly – Depress plunger steadily; withdraw at same angle.

  • Apply Pressure – Light pressure with gauze/cotton if needed.

Schedule

  • 6 days on / 1 day off, at a consistent daily time. Many protocols prefer bedtime on an empty stomach (2–3 hours after last meal) unless your prescriber advises otherwise.

After

  • Sharps Disposal – Place used needle/syringe in a sharps container.

Customer Questions & Answers

    No reviews yet. Be the first to write one!

Customer Reviews

0.0

out of 5.0
5 Star (0.0%)
4 Star (0.0%)
3 Star (0.0%)
2 Star (0.0%)
1 Star (0.0%)
How are ratings calculated?
Possible Side Effects

Possible Side Effects

Common (often dose/response related)

  • Injection-site redness/itching, mild bruising

  • Water retention/edema, joint or muscle aches, carpal-tunnel–like tingling

  • Increased appetite (ipamorelin), vivid dreams, headache, fatigue

Metabolic / Monitor

  • Hypoglycemia-like symptoms (shakiness, sweating, lightheadedness)

  • Fasting glucose/insulin changes, BP fluctuations

Serious (stop & seek care)

  • Severe allergic reaction (hives, facial swelling, wheeze)

  • Marked edema, shortness of breath, chest symptoms, vision changes

Not an exhaustive list. If effects are severe, persistent, or unusual, discontinue and contact your clinician.

Additional Information

Additional Information

What is the IGF-1 LR3 / CJC-1295 / Ipamorelin combo?
A three-agent GH/IGF-axis program:

  • IGF-1 LR3 – Long-acting IGF analogue supporting tissue repair/recovery.

  • CJC-1295 (non-DAC in daily protocols) – GHRH analogue supporting GH pulse amplitude.

  • Ipamorelin – GHRP/ghrelin receptor agonist supporting pulse frequency and may increase appetite.

How Does It Work?

  • Axis Synergy – CJC amplifies GH pulses, ipamorelin increases their frequency, and IGF-1 LR3 supports downstream recovery pathways for training and performance.

Who Can Use It?
Adults under clinician supervision seeking energy/performance/recovery support. Not recommended during pregnancy/breastfeeding, for minors, or with active malignancy. Use caution if you have diabetes/insulin resistance, sleep apnea, significant edema, or uncontrolled hypertension.

Clinical Supervision
Your clinician may monitor IGF-1, fasting glucose/insulin, lipids, BP, and symptom response.

Shipping Information

Shipping & Cold Storage

Storage

  • Refrigerate 2–8 °C (35–46 °F); do not freeze; protect from light.

  • If pharmacy-reconstituted, follow the labeled beyond-use date (commonly up to 14 days refrigerated).

Shipping

  • Cold-chain packaging with ice packs.

  • On arrival: Refrigerate promptly and inspect for temperature breach or damage before use.

PTNL
PTNL
62 Products

Best for Weightloss

  • 100% Authentic
  • 100 Days Return
  • 100 Months Warranty
  • Address: 7 Dell Rise, St Albans, United Kingdom
  • Contact Seller: +44 7789456012

Chat response

100%

Shipping

100%

Authenticity

100%

Become a Vendor? Register now

Frequently Asked Questions

Keep a consistent daily time. Many prefer bedtime, empty stomach (2–3 hours after last meal) unless directed otherwise.

The rest day may help maintain receptor responsiveness and manage side effects; follow your clinician’s plan.

Yes—ipamorelin may increase appetite, and IGF-axis support can impact glucose/insulin. Coordinate meal timing and monitor with your clinician.

Only under clinical supervision. Avoid unsupervised stacking of multiple GH/IGF-axis agents.

Subcutaneously in the abdomen, thigh, or upper arm. Rotate sites to minimize irritation.

These can be dose related. Inform your clinician—they may adjust dose/timing.

Skip and resume the next scheduled day; do not double dose.

Sleep/recovery changes may appear 1–2 weeks in; performance/comp trends typically 4–8+ weeks with training and nutrition.

Pregnant/breastfeeding individuals, minors, and anyone with active cancer. Use caution with uncontrolled hypertension, sleep apnea, significant edema, or diabetes.

Use an insulated bag with ice packs; keep upright; do not freeze; protect from light.